BTSG
BrightSpring Health·NASDAQ
--
--(--)
--
--(--)
5.89 / 10
Netural
Analyst coverage is positive with 33.3% Strong Buy and 66.7% Buy ratings, yielding a historical weighted rating of 3.99. Fund flow data show a good score of 7.8/10; while overall and block trends are negative, Small and Medium inflow trends are positive, suggesting accumulating institutional interest that offsets larger-scale selling.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
33%
Buy
67%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-18
InstitutionMizuho
Times predicted2
Historical Win Rate100.0%
What is the analyst consensus for BTSG?
- BTSG holds a Bearish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.89/10 (Netural).
